Zenitiva Pharmaceuticals India Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
- Paid Up Capital ₹ 0.10 M
- Company Age 6 Year, 5 Months
- Last Filing with ROC 31 Mar 2024
- Revenue Growth 49.85%
- Profit Growth 388.96%
- Ebitda 454.02%
- Net Worth 406.33%
- Total Assets 29.28%
About Zenitiva Pharmaceuticals India
Zenitiva Pharmaceuticals India Private Limited (ZPIPL) is a Private Limited Indian Non-Government Company incorporated in India on 10 August 2018 (Six years and five months 24 days old ). Its registered office is in Delhi, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Saurabh Jain, Dharmendra Srivastava, Jitendra Gautam, and Ten other members serve as directors at the Company.
Company Details
-
Location
Delhi, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
Social Media-
Corporate Identity Details
-
CIN/LLPIN
U74999DL2018PTC337446
-
Company No.
337446
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
10 Aug 2018
-
Date of AGM
30 Sep 2024
-
Date of Balance Sheet
31 Mar 2024
-
Listing Status
Unlisted
-
ROC Code
Roc Delhi
Industry
Who are the key members and board of directors at Zenitiva Pharmaceuticals India?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Sachin Dixit
|
Managing Director | 10-Aug-2018 | Current |
Board Members (12)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
|
Gaurav Gautam
|
Director | 11-Aug-2018 | Current |
|
Saurabh Jain
|
Director | 10-Aug-2018 | Current |
|
Dharmendra Srivastava
|
Director | 10-Aug-2018 | Current |
|
Jitendra Gautam
|
Director | 10-Aug-2018 | Current |
|
Sachin Garg
|
Director | 10-Aug-2018 | Current |
|
Jyoti Baijal
|
Director | 11-Aug-2018 | Current |
Financial Performance of Zenitiva Pharmaceuticals India.
Zenitiva Pharmaceuticals India Private Limited, for the financial year ended 2021, experienced significant growth in revenue, with a 49.85% increase. The company also saw a substantial improvement in profitability, with a 388.96% increase in profit. The company's net worth Soared by an impressive increase of 406.33%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Zenitiva Pharmaceuticals India?
In 2021, Zenitiva Pharmaceuticals India had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Zenitiva Pharmaceuticals India?
Zenitiva Pharmaceuticals India has a workforce of 16 employees as of Mar 21, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Zenitiva Pharmaceuticals India, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Zenitiva Pharmaceuticals India's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
